Lowe N J, Maxwell C A, Lowe P, Duick M G, Shah K
Cranley Clinic for Dermatology, London, England.
J Am Acad Dermatol. 2001 Dec;45(6):930-3. doi: 10.1067/mjd.2001.117381.
Hyaluronic acid (HA) fillers have been proposed as alternatives to other temporary skin fillers, such as bovine collagen, for treating facial skin lines and for providing lip augmentation. Several types of commercial HA fillers are now available in many countries. They include Restylane, which is produced by microbiologic engineering techniques, and Hylaform, which is HA extract derived from rooster combs. They have been approved for use in several countries, but not currently in the United States. There are no recommendations to perform pretreatment skin testing by the manufacturers.
Our purpose is to describe and comment on our experiences with Hylaform and Restylane fillers. Observation of any side effects and skin testing results were documented.
Between September 1996 and September 2000, 709 patients were treated with Hylaform and Restylane and were followed up clinically for at least 1 year. Three of these patients (0.42%) developed delayed skin reactions. Three other patients were referred for evaluation of their skin reactions from other practitioners. Five of these 6 patients agreed to skin testing of their forearms.
In the 5 patients tested, challenge intradermal skin testing was positive in 4 patients; the reactions started approximately 8 weeks after injection.
There was a slight incidence of delayed inflammatory skin reactions to two HA fillers. Both of these reactions occurred after the first and repeat injections. Challenge skin testing was positive in 4 of 5 tested patients.
透明质酸(HA)填充剂已被提议作为其他暂时性皮肤填充剂(如牛胶原蛋白)的替代品,用于治疗面部皮肤皱纹和丰唇。目前许多国家都有几种商用HA填充剂。其中包括通过微生物工程技术生产的瑞蓝(Restylane),以及从公鸡鸡冠提取的HA制成的海魅(Hylaform)。它们已在多个国家获批使用,但目前在美国尚未获批。制造商没有建议进行预处理皮肤测试。
我们的目的是描述和评论我们使用海魅和瑞蓝填充剂的经验。记录观察到的任何副作用和皮肤测试结果。
1996年9月至2000年9月期间,709例患者接受了海魅和瑞蓝治疗,并进行了至少1年的临床随访。其中3例患者(0.42%)出现了延迟性皮肤反应。另外3例患者由其他医生转诊来评估其皮肤反应。这6例患者中有5例同意在前臂进行皮肤测试。
在接受测试的5例患者中,4例皮内激发试验呈阳性;反应在注射后约8周开始。
两种HA填充剂均有轻微的延迟性炎症皮肤反应发生率。这两种反应均在首次注射和重复注射后出现。5例接受测试的患者中有4例激发皮肤试验呈阳性。